Alnylam RNAi 2010 Program Calls For Four New Business Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
Company also is targeting four new RNAi projects in clinical development by the end of 2010.
You may also be interested in...
Alnylam Strengthens IP Position With Acquisition Of Nucleonics Patent Estate
RNAi-focused biotech calls acquisition inexpensive, will prevent potential end-around of its intellectual property.
Alnylam Strengthens IP Position With Acquisition Of Nucleonics Patent Estate
RNAi-focused biotech calls acquisition inexpensive, will prevent potential end-around of its intellectual property.
Publication Of Regulus Preclinical Study Derisks Micro RNA Therapeutics
Article in Nature reports anti-miR-21 compound prevents heart failure in mouse model.